Conditions: Healthy Volunteers
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 34
Healthy volunteers: yes

Brief summary:
The purpose of this study is to determine the single-dose pharmacokinetics of the investigational drug PL 3100 following oral administration to healthy volunteers and to compare the pharmacokinetic profiles of PL 3100 and naproxen at a prescription dose.

Detailed description:

Arms:
arm 1: Active experimental drug arm 2: Active comparator

Interventions: intervention 1: Naproxen intervention 2: PL 3100
Intervention descriptions: intervention 1: Single orally administered dose of 500 mg naproxen intervention 2: Single orally administered dose of PL 3100 (500 mg naproxen)

Protocol document: